Stocks and Investing
Stocks and Investing
Wed, November 8, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Li Watsek Reiterated (BCYC) at Buy and Held Target at $65 on, Nov 8th, 2023
Li Watsek of Cantor Fitzgerald, Reiterated "Bicycle Therapeutics plc" (BCYC) at Buy and Held Target at $65 on, Nov 8th, 2023.
Li has made no other calls on BCYC in the last 4 months.
There are 6 other peers that have a rating on BCYC. Out of the 6 peers that are also analyzing BCYC, 1 agrees with Li's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Jeffrey Hung of "Morgan Stanley" Maintained at Hold with Decreased Target to $40 on, Friday, November 3rd, 2023
These are the ratings of the 5 analyists that currently disagree with Li
- Kalpit Patel of "B. Riley Securities" Upgraded from Hold to Strong Buy and Held Target at $33 on, Tuesday, September 12th, 2023
- Reni Benjamin of "JMP Securities" Reiterated at Buy and Held Target at $44 on, Tuesday, September 12th, 2023
- Ami Fadia of "Needham" Reiterated at Strong Buy and Held Target at $46 on, Tuesday, September 12th, 2023
- Swayampakula Ramakanth of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $57 on, Friday, August 4th, 2023
- Tony Butler of "EF Hutton" Reiterated at Strong Buy and Held Target at $50 on, Thursday, August 3rd, 2023
Contributing Sources